Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 516 | 118 | -156 | -1,475 | -1,431 |
| Depreciation Amortization | 317 | 226 | 120 | 555 | 405 |
| Accounts receivable | -6 | 316 | 174 | 61 | 309 |
| Accounts payable and accrued liabilities | -36 | 388 | -4 | -4 | 48 |
| Other Working Capital | -214 | 138 | 283 | -137 | 92 |
| Other Operating Activity | 93 | -610 | -125 | 402 | -10 |
| Operating Cash Flow | $670 | $577 | $293 | $-597 | $-587 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 86 | -1 | -2 | -19 | -4 |
| Other Investing Activity | -134 | -76 | -19 | -196 | -116 |
| Investing Cash Flow | $-48 | $-77 | $-21 | $-215 | $-120 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 225 | 225 | N/A | N/A | 0 |
| Debt Repayment | -7 | -3 | N/A | -5 | -5 |
| Other Financing Activity | -7 | -8 | 0 | -150 | -150 |
| Financing Cash Flow | $211 | $215 | $0 | $-155 | $-155 |
| Beginning Cash Position | 180 | 180 | 180 | 1,146 | 1,146 |
| End Cash Position | 1,014 | 894 | 452 | 180 | 285 |
| Net Cash Flow | $834 | $714 | $272 | $-966 | $-862 |
| Free Cash Flow | |||||
| Operating Cash Flow | 670 | 577 | 293 | -597 | -587 |
| Capital Expenditure | -14 | -1 | -2 | -19 | -4 |
| Free Cash Flow | 656 | 575 | 291 | -616 | -591 |